Tranexamic Acid for Anterior Cruciate Ligament Injury

This trial tests whether taking oral tranexamic acid (TXA) for a week after ACL surgery aids recovery. Researchers aim to determine if TXA can reduce knee pain, decrease the need for opioid pain medication, and improve knee movement two weeks post-surgery. Participants will receive either TXA or a placebo (a pill with no active drug) and will record pain and medication use in a diary. The trial targets individuals aged 14 to 25 undergoing ACL surgery with a specific type of graft and who meet certain health criteria. As a Phase 3 trial, it represents the final step before FDA approval, allowing participants to contribute to the potential approval of a new treatment.

Previous studies have shown that tranexamic acid (TXA) is well-tolerated by many people. The FDA has approved it to reduce bleeding during surgeries, indicating its general safety for that use. Many patients who have taken TXA report only mild side effects, such as nausea or diarrhea, with serious side effects being very rare.

Tranexamic Acid (TXA) is unique because it takes a proactive approach to managing bleeding in patients undergoing surgery for anterior cruciate ligament (ACL) injuries. Unlike traditional treatments that may only address bleeding after it starts, TXA works by preventing excessive bleeding from the get-go. The combination of oral and IV administration ensures that the medication is active both before and after the surgical procedure, potentially leading to better outcomes and faster recovery times. Researchers are excited about TXA because it could enhance surgical safety and efficiency by minimizing blood loss and reducing the need for blood transfusions.

Research has shown that tranexamic acid (TXA) can be very helpful after ACL surgery. In this trial, participants will receive either oral TXA or a placebo, in addition to standard IV TXA. Studies indicate that TXA reduces bleeding, swelling, and pain in the knee. It also seems to improve knee mobility and aid in removing excess fluid after surgery. Patients who received TXA reported less pain and required fewer pain medications early on. This suggests that TXA might help speed up recovery and improve knee function after ACL surgery.⁶⁷⁸⁹¹⁰